HHS Drug Price Plan Is a Gift to Global ‘Freeloaders’

Prescription drugs are costly, especially in the United States. That's why, in an effort to lower the prices Americans pay at the pharmacy, President Trump recently pledged to end "the global freeloading that forces American consumers to subsidize lower prices in foreign countries." 

Unfortunately, a new plan from the Department of Health and Human Services undermines this goal. 

HHS Sec. Alex Azar recently unveiled a new Medicare proposal that simply copies the foreign price-control policies that have enabled other countries to underpay for drugs for so long. Not only does the change fail to hold "freeloading" countries accountable — it will undermine access to life-changing medicines here in the United States.

Why are brand-name drugs cheaper in foreign countries than they are here in the United States? Simply put, it's because of price controls. In countries like the United Kingdom, Canada, France, and Sweden, the government dictates what drug companies can charge for their products.  
 
The prices of prescription drugs sold in Sweden, for instance, are determined by the Pharmaceutical Benefits Board. Canada's Patented Medicine Prices Review Board plays a similar role. So does France's Economic Committee on Health Care Products.  

 
Sign Up for Our Email Newsletter

RECENT NEWS

Vaper Madness

Vaper Madness

E-cigarettes, while not a cure for nicotine dependence, can help reduce the death and disease caused by combustible tobac...  Read more

Three ways Congress can lower seniors’ pharmacy bills

Three ways Congress can lower seniors’ pharmacy bills

Here are three ways Congress can improve Medicare Part D to lower seniors’ drug tabs....  Read more

FDA Hears Concerns About The Unregulated CBD Market

FDA Hears Concerns About The Unregulated CBD Market

What most speakers agreed on: the need for federal CBD oversight for production quality, more testing and research and be...  Read more

DRUGWONKS BLOG